Fig. 1.

Relivion^®MG system. The eCOT-NS device provides noninvasive neuromodulation by concurrently stimulating the two primary nerve pathways in the brain associated with migraine, precisely targeting six nerve branches across the occipital and trigeminal nerves. The device is connected to a custom mobile application designed to upload treatment data to a cloud database. Treatment reports and metrices are available to the physician over a web-based interface. TCC, trigeminocervical complex; Channel 1, occipital stimulation channel; Channel 2 and Channel 3, trigeminal (supraorbital/supratrochlear) stimulation channels; numbers 1–6 represent the six electrodes